Cargando…
Editorial: Biomarkers and Pathogenesis of Alpha-Synuclein in Parkinson's Disease
Autores principales: | Li, Puyu, Xu, Pingyi, Liu, Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8523817/ https://www.ncbi.nlm.nih.gov/pubmed/34675800 http://dx.doi.org/10.3389/fnagi.2021.776873 |
Ejemplares similares
-
Alpha-Synuclein as a Biomarker of Parkinson’s Disease: Good, but Not Good Enough
por: Ganguly, Upasana, et al.
Publicado: (2021) -
Interaction of Alpha-Synuclein With Lipids: Mitochondrial Cardiolipin as a Critical Player in the Pathogenesis of Parkinson’s Disease
por: Gilmozzi, Valentina, et al.
Publicado: (2020) -
New Perspectives on Roles of Alpha-Synuclein in Parkinson’s Disease
por: Zhang, Guoxin, et al.
Publicado: (2018) -
Alpha-Synuclein Pathology and the Role of the Microbiota in Parkinson’s Disease
por: Fitzgerald, Emily, et al.
Publicado: (2019) -
Targeting Alpha-Synuclein as a Therapy for Parkinson’s Disease
por: Fields, Carroll Rutherford, et al.
Publicado: (2019)